KINETIC CHARACTERIZATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND T-PA DELETION MUTANTS

被引:0
|
作者
DEVRIES, C
VEERMAN, H
NESHEIM, ME
PANNEKOEK, H
机构
[1] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT MOLEC BIOL,POB 9406,1006 AK AMSTERDAM,NETHERLANDS
[2] QUEENS UNIV,DEPT BIOCHEM,KINGSTON K7L 3N6,ONTARIO,CANADA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The binding of t-PA to fibrin is mediated both by its "finger" (F) and its "kringle 2" (K2) domain. In addition, these domains are involved in the stimulation of t-PA activity by fibrin. We analyzed the kinetic characteristics of Glu-plasminogen activation by t-PA and a set of t-PA deletion mutants in the absence and the presence of desA-fibrin. In the absence of desA-fibrin, the activity of t-PA (variants) is determined by the presence of the protease domain, irrespective of the composition of the amino-terminal heavy chain. In the presence of the cofactor desA-fibrin, the activity of t-PA (variants) is dependent on the domain composition of the heavy chain. The activity of t-PA is stimulated 2,400 fold by desA-fibrin, whereas the activity of the mutant lacking the K1 domain (del. K1) increases 936 fold in the presence of this cofactor. Mutants lacking either the K2 domain (del. K2) or the F domain (del. F) exhibit an enhanced activity upon desA-fibrin addition of 200 and 210 fold, respectively. DesA-fibrin has no stimulatory effect on the activity of the mutant containing only the serine-protease domain (del.FE K1 K2) nor on the activity of the variant containing only the K1 domain and the serine-protease domain (del. FE K2). Furthermore, we determined the relative fibrin affinity of each t-PA variant, which is similarly dictated by the composition of the heavy chain.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 50 条
  • [1] FUNCTIONAL-CHARACTERIZATION OF A MONOCLONAL ANTI TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) ANTIBODY STIMULATING PLASMINOGEN-ACTIVATOR ACTIVITY OF T-PA
    WOJTA, J
    BECKMANN, R
    TURCU, L
    BINDER, BR
    THROMBOSIS RESEARCH, 1986, : 19 - 19
  • [2] CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)
    SOBEL, BE
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 53 - 53
  • [3] CHARACTERIZATION OF MUTANTS OF A CHIMERIC T-PA/U-PA PLASMINOGEN-ACTIVATOR OBTAINED BY DELETION AND/OR REPLACEMENT OF T-PA DOMAINS
    NELLES, L
    LIJNEN, HR
    VANNUFFELEN, A
    DECOCK, F
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 541 - 541
  • [4] THROMBOLYTIC TREATMENT WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) CONTAINING LIPOSOMES IN RABBITS - A COMPARISON WITH FREE T-PA
    HEEREMANS, JLM
    PREVOST, R
    BEKKERS, MEA
    LOS, P
    EMEIS, JJ
    KLUFT, C
    CROMMELIN, DJA
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (03) : 488 - 494
  • [5] THE STABILITY OF TISSUE PLASMINOGEN-ACTIVATOR (T-PA)
    GAFFNEY, PJ
    TEMPLEMAN, J
    CURTIS, AD
    CAMPBELL, PJ
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (03) : 650 - 651
  • [6] THROMBOLYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) - INFLUENCE OF PLASMINOGEN-ACTIVATOR INHIBITOR (PA-I)
    COLUCCI, M
    PARAMO, JA
    STASSEN, JM
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 217 - 217
  • [7] CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) - COMPARISON WITH UROKINASE
    SUSAWA, T
    HATTORI, R
    SAKAGUCHI, K
    TAKAHASHI, M
    AOYAMA, T
    TAKATSU, Y
    YUI, N
    YUI, Y
    KAWAI, C
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (06): : 552 - 552
  • [8] DOMAIN-STRUCTURE OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)
    VANZONNEVELD, AJ
    VEERMAN, H
    PANNEKOEK, H
    HAEMOSTASIS, 1986, 16 : 5 - 5
  • [10] TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) - AN AGENT WITH PROMISE FOR SELECTIVE THROMBOLYSIS
    TIEFENBRUNN, AJ
    SOBEL, BE
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1985, 7 (01) : 82 - 86